Avik Chatterjee, MD, MPH
Assistant Professor, Medicine
Biography
Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.
Other Positions
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
Education
- University of North Carolina at Chapel Hill, MD
Publications
- Published on 2/1/2024
Mayer M, Mejia Urieta Y, Martinez LS, Komaromy M, Hughes U, Chatterjee A. Encampment Clearings And Transitional Housing: A Qualitative Analysis Of Resident Perspectives. Health Aff (Millwood). 2024 Feb; 43(2):218-225. PMID: 38315933.
Read at: PubMed - Published on 12/19/2023
Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, Kinnard EN, McAlearney AS, Bosak J, Medley B, Pinkhover A, Taylor JL, Samet JH, Lunze K. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat. 2024 Apr; 159:209272. PMID: 38128649.
Read at: PubMed - Published on 12/1/2023
Chatterjee A, Obando A. LGBTQ+ Youth Experiencing Homelessness: Health Impacts and a Call to Action. Pediatrics. 2023 Dec 01; 152(6). PMID: 37981854.
Read at: PubMed - Published on 8/28/2023
Zang X, Walley AY, Chatterjee A, Kimmel SD, Morgan JR, Murphy SM, Linas BP, Nolen S, Reilly B, Urquhart C, Schackman BR, Marshall BDL. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Addiction. 2023 Dec; 118(12):2413-2423. PMID: 37640687.
Read at: PubMed - Published on 7/5/2023
Chatterjee A, Yan S, Lambert A, Morgan JR, Green TC, Jeng PJ, Jalali A, Xuan Z, Krieger M, Marshall BDL, Walley AY, Murphy SM. Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019. Health Serv Res. 2023 Oct; 58(5):1141-1150. PMID: 37408299.
Read at: PubMed - Published on 5/18/2023
Swartz N, Odayappan S, Chatterjee A, Cutler D. Impact of Medicaid expansion on inclusion of medications for opioid use disorder in homeless adults' treatment plans. J Subst Use Addict Treat. 2023 Sep; 152:209059. PMID: 37207834.
Read at: PubMed - Published on 4/19/2023
Dang N, Khunte M, Zhong A, Chatterjee A. Naloxone Online Information Exceeds the Recommended Reading Level for Patient Education Materials. J Stud Alcohol Drugs. 2023 Sep; 84(5):680-683. PMID: 37096779.
Read at: PubMed - Published on 4/5/2023
Chatterjee A, Bannister M, Hill LG, Davis CS. Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care. J Gen Intern Med. 2023 Jun; 38(8):1980-1983. PMID: 37020124.
Read at: PubMed - Published on 4/3/2023
Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani RWMA, Potee RA, Ryan D, Murphy SM, Walley AY, Linas BP. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts. JAMA Netw Open. 2023 Apr 03; 6(4):e237036. PMID: 37058306.
Read at: PubMed - Published on 11/11/2022
Chatterjee A, Dunleavy S, Gonzalez T, Benson J, Henault L, MacIntosh A, Goodell K, Witzburg R, Paasche-Orlow M. Health professions school applicant experiences of discrimination during interviews. Med Teach. 2023 May; 45(5):532-541. PMID: 36369780.
Read at: PubMed
View 40 more publications: View full profile at BUMC